Sofwave Medical To Participate In The Needham 23Rd Annual Healthcare Conference
Date
3/28/2024 8:03:22 AM
(MENAFN- GlobeNewsWire - Nasdaq) SAN CLEMENTE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today announced that Louis Scafuri, Chief Executive Officer, and Assaf Korner, Chief financial Officer, will provide a corporate update and participate in one-on-one investor meetings at the Needham 23rd Annual Healthcare Conference, to be held virtually from April 8-11, 2024.
Needham 23rd Annual Healthcare Conference
Format: Corporate update and one-on-one investor meetings
Presentation Date: Tuesday, April 9, 2024
Presentation Time: 10:15 a.m. ET
Webcast: Click Here
About Sofwave Medical Ltd.
Sofwave Medical Ltd. has implemented an innovative approach to wrinkle reduction lifting and cellulite using its proprietary breakthrough technology. SUPERBTM, Synchronous Ultrasound Parallel Beam technology is FDA-cleared to improve facial lines and wrinkles, lifting the eyebrow and lifting lax submental tissue (beneath the chin), neck tissue and arm, as well as the short-term improvement in the appearance of cellulite and treatment of acne scars, providing physicians with smart yet simple, effective, and safe aesthetic solutions for their patients.
Contact - ...
Investor Contact:
Brian Ritchie
LifeSci Advisors LLC
(212) 915-2578
...
MENAFN28032024004107003653ID1108032251
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.